159 related articles for article (PubMed ID: 23128359)
1. Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency.
Donehower LA
Aging (Albany NY); 2012 Oct; 4(10):660-1. PubMed ID: 23128359
[TBL] [Abstract][Full Text] [Related]
2. New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-/- mice by delaying carcinogenesis.
Comas M; Toshkov I; Kuropatwinski KK; Chernova OB; Polinsky A; Blagosklonny MV; Gudkov AV; Antoch MP
Aging (Albany NY); 2012 Oct; 4(10):715-22. PubMed ID: 23117593
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/- mice.
Komarova EA; Antoch MP; Novototskaya LR; Chernova OB; Paszkiewicz G; Leontieva OV; Blagosklonny MV; Gudkov AV
Aging (Albany NY); 2012 Oct; 4(10):709-14. PubMed ID: 23123616
[TBL] [Abstract][Full Text] [Related]
4. Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin.
Popovich IG; Anisimov VN; Zabezhinski MA; Semenchenko AV; Tyndyk ML; Yurova MN; Blagosklonny MV
Cancer Biol Ther; 2014 May; 15(5):586-92. PubMed ID: 24556924
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice.
Anisimov VN; Zabezhinski MA; Popovich IG; Piskunova TS; Semenchenko AV; Tyndyk ML; Yurova MN; Rosenfeld SV; Blagosklonny MV
Cell Cycle; 2011 Dec; 10(24):4230-6. PubMed ID: 22107964
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin extends maximal lifespan in cancer-prone mice.
Anisimov VN; Zabezhinski MA; Popovich IG; Piskunova TS; Semenchenko AV; Tyndyk ML; Yurova MN; Antoch MP; Blagosklonny MV
Am J Pathol; 2010 May; 176(5):2092-7. PubMed ID: 20363920
[TBL] [Abstract][Full Text] [Related]
7. Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats.
Lesovaya EA; Kirsanov KI; Antoshina EE; Trukhanova LS; Gorkova TG; Shipaeva EV; Salimov RM; Belitsky GA; Blagosklonny MV; Yakubovskaya MG; Chernova OB
Oncotarget; 2015; 6(12):9718-27. PubMed ID: 25991667
[TBL] [Abstract][Full Text] [Related]
8. Haploinsufficiency of
Ghosh S; Wong SK; Jiang Z; Liu B; Wang Y; Hao Q; Gorbunova V; Liu X; Zhou Z
Elife; 2018 Feb; 7():. PubMed ID: 29474172
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin extends murine lifespan but has limited effects on aging.
Neff F; Flores-Dominguez D; Ryan DP; Horsch M; Schröder S; Adler T; Afonso LC; Aguilar-Pimentel JA; Becker L; Garrett L; Hans W; Hettich MM; Holtmeier R; Hölter SM; Moreth K; Prehn C; Puk O; Rácz I; Rathkolb B; Rozman J; Naton B; Ordemann R; Adamski J; Beckers J; Bekeredjian R; Busch DH; Ehninger G; Graw J; Höfler H; Klingenspor M; Klopstock T; Ollert M; Stypmann J; Wolf E; Wurst W; Zimmer A; Fuchs H; Gailus-Durner V; Hrabe de Angelis M; Ehninger D
J Clin Invest; 2013 Aug; 123(8):3272-91. PubMed ID: 23863708
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.
Harrison DE; Strong R; Sharp ZD; Nelson JF; Astle CM; Flurkey K; Nadon NL; Wilkinson JE; Frenkel K; Carter CS; Pahor M; Javors MA; Fernandez E; Miller RA
Nature; 2009 Jul; 460(7253):392-5. PubMed ID: 19587680
[TBL] [Abstract][Full Text] [Related]
12. Balancing and Differentiating p53 Activities toward Longevity and No Cancer?
Horikawa I
Cancer Res; 2020 Dec; 80(23):5164-5165. PubMed ID: 33268555
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of off-label rapamycin use to promote healthspan in 333 adults.
Kaeberlein TL; Green AS; Haddad G; Hudson J; Isman A; Nyquist A; Rosen BS; Suh Y; Zalzala S; Zhang X; Blagosklonny MV; An JY; Kaeberlein M
Geroscience; 2023 Oct; 45(5):2757-2768. PubMed ID: 37191826
[TBL] [Abstract][Full Text] [Related]
14. Depletion of Rictor, an essential protein component of mTORC2, decreases male lifespan.
Lamming DW; Mihaylova MM; Katajisto P; Baar EL; Yilmaz OH; Hutchins A; Gultekin Y; Gaither R; Sabatini DM
Aging Cell; 2014 Oct; 13(5):911-7. PubMed ID: 25059582
[TBL] [Abstract][Full Text] [Related]
15. Longevity, aging and rapamycin.
Ehninger D; Neff F; Xie K
Cell Mol Life Sci; 2014 Nov; 71(22):4325-46. PubMed ID: 25015322
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island.
Arriola Apelo SI; Lamming DW
J Gerontol A Biol Sci Med Sci; 2016 Jul; 71(7):841-9. PubMed ID: 27208895
[TBL] [Abstract][Full Text] [Related]
17. Transient rapamycin treatment during developmental stage extends lifespan in Mus musculus and Drosophila melanogaster.
Aiello G; Sabino C; Pernici D; Audano M; Antonica F; Gianesello M; Ballabio C; Quattrone A; Mitro N; Romanel A; Soldano A; Tiberi L
EMBO Rep; 2022 Sep; 23(9):e55299. PubMed ID: 35796299
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of C/EBPβ-LIP extends health and lifespan in mice.
Müller C; Zidek LM; Ackermann T; de Jong T; Liu P; Kliche V; Zaini MA; Kortman G; Harkema L; Verbeek DS; Tuckermann JP; von Maltzahn J; de Bruin A; Guryev V; Wang ZQ; Calkhoven CF
Elife; 2018 Jun; 7():. PubMed ID: 29708496
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin improves healthspan but not inflammaging in nfκb1
Correia-Melo C; Birch J; Fielder E; Rahmatika D; Taylor J; Chapman J; Lagnado A; Carroll BM; Miwa S; Richardson G; Jurk D; Oakley F; Mann J; Mann DA; Korolchuk VI; Passos JF
Aging Cell; 2019 Feb; 18(1):e12882. PubMed ID: 30468013
[TBL] [Abstract][Full Text] [Related]
20. Haploinsufficiency of the Myc regulator Mtbp extends survival and delays tumor development in aging mice.
Grieb BC; Boyd K; Mitra R; Eischen CM
Aging (Albany NY); 2016 Oct; 8(10):2590-2602. PubMed ID: 27803394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
